Phibro Animal Health PAHC
NASDAQ PAHC
$36.80 -0.51 (-1.37%)
As of: Sep 9, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022)

Phibro Animal Health (PAHC) posted Non-Current Deferred Tax Liability of $8.8 million for Q1 2022, up 9.72% on a QoQ basis from $8.1 million in Q4 2021, and down 28.45% year-over-year from $12.4 million in Q1 2021.

Analysis

Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022) Analysis & Trends

Phibro Animal Health has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $8.8 million in Q1 2022.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 28.45% year-over-year to $8.8 million in Q1 2022; TTM through Mar 2022 was $8.8 million, a 28.45% decrease from a year earlier, with the FY2021 full-year figure at $6.6 million, down 43.1% from the prior year.
  • Non-Current Deferred Tax Liability was $8.8 million for Q1 2022 at Phibro Animal Health, up from $8.1 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $12.4 million in Q1 2021, with the low at $6.6 million in Q2 2021.
  • Average Non-Current Deferred Tax Liability over 4 years is $9.4 million, with a median of $9.0 million recorded in 2019.
  • The largest YoY upside for Non-Current Deferred Tax Liability was 33.1% in 2021 against a maximum downside of 43.1% in 2021.
  • Over 4 years, Non-Current Deferred Tax Liability stood at $9.5 million in 2019, then grew by 26.6% to $12.1 million in 2020, then tumbled by 33.09% to $8.1 million in 2021, then advanced by 9.72% to $8.8 million in 2022.
  • The last three Non-Current Deferred Tax Liability figures came in at $8.8 million (Q1 2022), $8.1 million (Q4 2021), and $7.3 million (Q3 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 42.23 Bn 42.03 Bn 779.09 Mn
2 Zoetis 31.39 Bn 29.72 Bn 1.05 Bn
3 Elanco Animal Health 12.21 Bn 11.68 Bn 798.00 Mn
4 Phibro Animal Health 1.55 Bn 1.47 Bn 134.40 Mn
5 Immucell 89.91 Mn 81.05 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 76.30 Mn 77.22 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 8.85 Mn
Dec 31, 2021 8.06 Mn
Sep 30, 2021 7.30 Mn
Jun 30, 2021 6.65 Mn
Mar 31, 2021 12.37 Mn
Dec 31, 2020 12.05 Mn
Jun 30, 2020 11.68 Mn
Mar 31, 2020 9.29 Mn
Dec 31, 2019 9.52 Mn
Sep 30, 2019 9.02 Mn
Jun 30, 2019 8.98 Mn